[These findings identify NSD3 as a novel critical oncogenic component and potential therapeutic target in NMC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE